Moreover, a recent study demonstrated that the high endogenous expression of AR in breast cancer cells potently and constitutively down-regulates the expression of Dikkopf1, a secreted inhibitor of the Wnt/β-catenin pathway [64]. Here, AR is linked to breast cancer.